Announcement on Subsidiary Obtaining Philippine Drug Registration Certificate for Pregabalin Capsules
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Filed with SSE · · 2 pages · Chinese
Shanghai Pharmaceuticals Holding Co. Ltd. announced that its subsidiary has received a drug registration certificate for Pregabalin Capsules from the Philippine Food and Drug Administration, allowing the product to be marketed in the Philippines.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Announcement on Subsidiary Obtaining Philippine Drug Registration Certificate for Pregabalin Capsules
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Shanghai Pharmaceuticals Holding Co. Ltd. on 6ix
Follow Shanghai Pharmaceuticals into a list and get an email when it puts out news.
Follow Shanghai Pharmaceuticals